PDA Annual 2012 – Novatek Speaks to Mike Parkes, COO of RCA Regulatory Compliance Associates

May 16th, 2012

Novatek International speaks to Mike Parkes, COO of RCA Regulatory Compliance Associates at the 2012 PDA Annual in Phoenix Arizona.

TRANSCRIPT:

Cheryl: “We are at PDA annual at Phoneix Arizona. It is an honor and a pleasure to be standing here with Mike Parkes. He is the COO of RCA.”

What I wanted to ask you today is where do you think is the biggest area of improvement within a Quality Organization?

Mike: “Thanks Cheryl. So I think one of the most significant opportunities that quality organizations have is that they are focused on regulatory compliance and that’s the price of admission and they have to do that…focus on release of product when it’s supposed to be released and not before that.

But an opportunity to drive business results is shortening the time between when the product is made and when it is actually released before commercial sale and the quality organization really holds the keys to the kingdom in terms of when product is released and it is a great opportunity for a quality organization to drive business results.”

 

2012 PDA Annual Meeting – Booth 512

April 1st, 2012

April 16-18, 2012 – Phoenix, AZ

Novatek International will be exhibiting its process-based LIMS software solutions at the 2012 PDA Annual Meeting: Manufacturing Innovation: Achieving Excellence in Sterileand Emerging Biopharmaceutical Technology, April 16-18, 2012 in Phoenix, AZ USA Come visit us at Booth #512 for a live demonstration.

For more detail follow this link:
2012 PDA Annual Meeting

Current Contract Manufacturing Operation (CMO) Regulatory Issues

March 20th, 2012

Featuring a Summary of Ben Venue Issues

Policy changes and enforcement strategies implemented by the FDA have led to an increase in the number of inspection of both Contract Manufacturing Operations (CMOs) and in-house sterile manufacturers — especially injectables. There has been a greater oversight and detailed review of all protocols and processes. Any issue or potential issue must have a corrective action with a demonstrated positive outcome. There no longer exists a prescribed sequence of events after a Form FDA 483 is issued. Contract Manufacturing Operations, in particular, must now have strategies to ensure GMP compliance at their facilities involved in “arms length” activities with innovator and generic firms and be prepared for more frequent and thorough audits.  » Read more: Current Contract Manufacturing Operation (CMO) Regulatory Issues

Pittcon Conference & Expo – Booth 1884

February 23rd, 2012

March 12-15, 2012 – Orlando, FL

Novatek International will be exhibiting its process-based LIMS software solutions at the Pittcon Conference & Expo from March 11-15, 2012 in Orlando, FL USA. Come visit us at Booth #1884 for a live demonstration.

For more details follow this link:
Pittcon Conference & Expo